Provided by Tiger Trade Technology Pte. Ltd.

Therapeutics

4.52
-0.2000-4.24%
Pre-market: 4.990.4700+10.40%07:20 EDT
Volume:977.97K
Turnover:4.46M
Market Cap:141.43M
PE:-1.09
High:4.77
Open:4.71
Low:4.50
Close:4.72
52wk High:50.40
52wk Low:4.50
Shares:31.29M
Float Shares:18.39M
Volume Ratio:1.51
T/O Rate:5.32%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-4.1300
EPS(LYR):-2.8503
ROE:-59.21%
ROA:-37.36%
PB:0.65
PE(LYR):-1.59

Loading ...

Wedbush Downgrades TScan Therapeutics to Neutral From Outperform, Adjusts Price Target to $1 From $5

MT Newswires Live
·
Sep 02

Allogene Therapeutics Announces Retirement of Chief Financial Officer Geoffrey Parker

GlobeNewswire
·
Sep 02

Acrivon Therapeutics to Present at the 2026 Cantor Global Healthcare Conference

GlobeNewswire
·
Sep 02

TScan Therapeutics Restructures to Focus on Solid Tumors

TIPRANKS
·
Sep 02

TScan Therapeutics Announces Strategic Reorganization to Focus on in vivo Cell Therapy for Solid Tumors

GlobeNewswire
·
Sep 02

Goldman Sachs Sticks to Their Hold Rating for Ocumension Therapeutics (1477)

TIPRANKS
·
Sep 02

Aptabio Therapeutics Plans Seoul NDR to Deepen R&D Dialogue with Institutions

TIPRANKS
·
Sep 02

Retail Employees Super Fund Exits Substantial Holding in PYC Therapeutics

TIPRANKS
·
Sep 02

Prescient Therapeutics Hits Dose Optimization Review Milestone in Cancer Drug Study

MT Newswires Live
·
Sep 02

Kazia Therapeutics is Maintained at Buy by BTIG

Dow Jones
·
Sep 01

BioMarin Completes Acquisition of Dutch Biotech Alesta Therapeutics

TIPRANKS
·
Sep 01

Kazia Therapeutics price target raised to $40 from $34 at BTIG

TIPRANKS
·
Sep 01

HighTide Therapeutics Grants Performance-Linked Share Options and Awards

TIPRANKS
·
Sep 01

Press Release: BioMarin Announces Close of the Alesta Therapeutics Acquisition

Dow Jones
·
Sep 01

Analyst Maintains Buy on Tenax Therapeutics as Subgroup Data Support Drug’s Potential; Price Target Reiterated at $4

TIPRANKS
·
Sep 01

Kazia Therapeutics Reports Preclinical Tumor Reduction in Colorectal Cancer Study

MT Newswires Live
·
Sep 01

Ocumension Therapeutics' Application for Ocular Inflammation Drug Accepted in China

MT Newswires Live
·
Sep 01

Metagenomi Therapeutics, Inc. to Present at the Wells Fargo 21st Annual Healthcare Conference

GlobeNewswire
·
Sep 01

Relmada Therapeutics to Participate at the Wells Fargo 21st Annual Healthcare Conference

GlobeNewswire
·
Sep 01

Dianthus Therapeutics to Participate in Three Investor Conferences During September

GlobeNewswire
·
Sep 01